Year archive

Sihuan Pharmaceutical Holdings Group Ltd. — 2026 filings

All 40 regulatory filings released by Sihuan Pharmaceutical Holdings Group Ltd. (460) in 2026, sourced directly from the official regulator.

40 Filings

2026 Period

2026 filings (40)

Filing	Released	Lang
Notification Letter and Request Form to Non-registered Holder Regulatory Filings	2026-06-02	English
Notification Letter and Change Request Form to Registered Shareholder Regulatory Filings	2026-06-02	English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING Regulatory Filings	2026-06-02	English
NOTICE OF ANNUAL GENERAL MEETING Regulatory Filings	2026-06-02	English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, DECLARATION AND PAYMENT OF A FINAL CASH DIVIDEND, RE-ELECTION OF RETIRING DIRECTORS, RE-APPOINTMENT OF AUDITOR, PROPOSED ADOPTION Regulatory Filings	2026-06-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026 Regulatory Filings	2026-06-01	English
VOLUNTARY ANNOUNCEMENT- SIHUAN PHARMACEUTICAL SIGNS COOPERATION AGREEMENT WITH DPROTEIN TO DEEPEN STRATEGIC LAYOUT OF AI IN THE FULL INDUSTRIAL CHAIN OF MEDICAL AESTHETICS AND INNOVATIVE DRUGS Capital/Financing Update	2026-05-28	English
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO THE SHARE AWARD SCHEME Transaction in Own Shares	2026-05-27	English
VOLUNTARY ANNOUNCEMENT SHARE REPURCHASE Transaction in Own Shares	2026-05-18	English
Next Day Disclosure Return Transaction in Own Shares	2026-05-18	English
VOLUNTARY ANNOUNCEMENT SHARE REPURCHASE Transaction in Own Shares	2026-05-13	English
Next Day Disclosure Return Transaction in Own Shares	2026-05-13	English
VOLUNTARY ANNOUNCEMENT-COMPLETION OF THE H SHARE FULL CIRCULATION BY XUANZHU BIOPHARM Share Issue/Capital Change	2026-05-12	English
PROPOSED ADOPTION OF THE 2026 SHARE INCENTIVE SCHEME Regulatory Filings	2026-05-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026 Regulatory Filings	2026-05-04	English
Notification Letter and Change Request Form to Registered Shareholder Report Publication Announcement	2026-04-27	English
Notification Letter and Request Form to Non-registered Holder Report Publication Announcement	2026-04-27	English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025 Regulatory Filings	2026-04-27	English
ANNUAL REPORT 2025 Regulatory Filings	2026-04-27	English
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO THE SHARE AWARD SCHEME Transaction in Own Shares	2026-04-21	English
VOLUNTARY ANNOUNCEMENT- RESULTS OF PRELIMINARY DATA FROM THE PHASE 1b FORTRESS CLINICAL STUDY OF NG-350A PRESENTED AT THE 2026 AACR Regulatory Filings	2026-04-20	English
VOLUNTARY ANNOUNCEMENT-RESULTS OF PHASE III CLINICAL DATA OF DIROZALKIB FOR THE FIRST-LINE TREATMENT OF ALK POSITIVE ADVANCED NSCLC PRESENTED AT THE 2026 AACR Regulatory Filings	2026-04-20	English
VOLUNTARY ANNOUNCEMENT- APPROVAL BY THE STOCK EXCHANGE REGARDING THE APPLICATION FOR THE PROPOSED IMPLEMENTATION OF H SHARE FULL CIRCULATION OF XUANZHU BIOPHARM Capital/Financing Update	2026-04-17	English
VOLUNTARY ANNOUNCEMENT- APPROVAL TO INITIATE A PHASE III CLINICAL TRIAL FOR NEW INDICATION OF ANAPRAZOLE SODIUM Regulatory Filings	2026-04-15	English
VOLUNTARY ANNOUNCEMENT - NOTIFICATION LETTER OF THE CSRC REGARDING THE APPLICATION FOR THE PROPOSED IMPLEMENTATION OF H SHARE FULL CIRCULATION OF XUANZHU BIOPHARM Share Issue/Capital Change	2026-04-12	English
VOLUNTARY ANNOUNCEMENT - LICENSING AND SUPPLY AGREEMENT REACHED BETWEEN XUANZHU BIOPHARM AND BOSTON ONCOLOGY FOR BIREOCICLIB AND DIROZALKIB Regulatory Filings	2026-04-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026 Regulatory Filings	2026-04-01	English
Final Cash Dividend for the year ended 31 December 2025 Notice of Dividend Amount	2026-03-31	English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025 Earnings Release FY 2025	2026-03-31	English
ANNOUNCEMENT ON RESULTS OF SUBSIDIARY Regulatory Filings	2026-03-30	English
VOLUNTARY ANNOUNCEMENT- FINAL ANALYSIS RESULTS OF THE PHASE 3 CLINICAL STUDY (BRIGHT-2) OF BIREOCICLIB IN COMBINATION WITH FULVESTRANT FOR THE TREATMENT OF HR+/HER2- ADVANCED BREAST CANCER PUBLISHED I Regulatory Filings	2026-03-24	English
VOLUNTARY ANNOUNCEMENT- COMPLETION OF ENROLLMENT OF ALL SUBJECTS IN PHASE III CLINICAL TRIAL IN CHINA OF ANAPRAZOLE SODIUM ENTERIC-COATED TABLETS (AN JIU WEI) FOR THE TREATMENT OF REFLUX ESOPHAGITIS Regulatory Filings	2026-03-22	English
NOTICE OF BOARD MEETING Report Publication Announcement	2026-03-19	English
VOLUNTARY ANNOUNCEMENT- INCLUSION OF THE SHARES OF XUANZHU BIOPHARM IN STOCK LIST OF HONG KONG STOCK CONNECT Regulatory Filings	2026-03-08	English
VOLUNTARY ANNOUNCEMENT-MARKETING APPROVAL FOR THE THIRD INDICATION OF XUANYUENING (BIREOCICLIB TABLETS) FOR THE FIRST-LINE TREATMENT OF HR+/HER2- ADVANCED BREAST CANCER GRANTED BY THE NMPA Regulatory Filings	2026-03-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026 Regulatory Filings	2026-03-02	English
VOLUNTARY ANNOUNCEMENT-XUANZHU BIOPHARM INCLUDED AS A CONSTITUENT STOCK OF THE HANG SENG COMPOSITE INDEX Regulatory Filings	2026-02-22	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026 Share Issue/Capital Change	2026-02-02	English
VOLUNTARY ANNOUNCEMENT-NEW SPECIFICATIONS OF PLLA FILLER OF SIHUAN PHARMACEUTICAL APPROVED FOR MARKET BY NMPA Regulatory Filings	2026-01-16	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025 Share Issue/Capital Change	2026-01-02	English

Filings by year

2026 40 filings
2025 93 filings
2024 55 filings
2023 68 filings
2022 73 filings
2021 126 filings
2020 53 filings
2019 45 filings
2018 39 filings
2017 60 filings
2016 88 filings
2015 49 filings
2014 44 filings
2013 41 filings
2012 38 filings
2011 46 filings
2010 11 filings